David Eric Cohen
Independent DirectorDr. David Eric Cohen, M.D., M.P.H, serves as Director at Trex Wind-down, Inc. (formerly known as Timber Pharmaceuticals, Inc.) since August 2020. Dr. Cohen is Director of Dualitas Therapeutics, Inc. from April 2026. Dr. Cohen is the Vice Chairman at Clinical Affairs and Associate Professor of Dermatology at the New York University School of Medicine. Dr. Cohen is the Charles C. and Dorothea E. Harris Professor of Dermatology at New York University School of Medicine, where he also serves as Chief of Allergy and Contact Dermatitis, Vice Chairman of Clinical Affairs and Director of Occupational and Environmental Dermatology. Dr. Cohen joined the NYU faculty in 1994 and his work has concentrated on cutaneous allergic and toxic reactions to exogenous and photo-reactive chemicals and the interaction of environmental stressors on the skin. Dr. Cohen has previously served as a lecturer of Environmental Sciences at Columbia University School of Public Health since 1993 and has served as an Affiliated Faculty Member of the NYU Global Institute of Public Health since 2014. He is a Member of International Dermatology Advisory Board at Peplin Inc. Dr. Cohen serves as Member of Scientific Advisory Board at Tinea Pharmaceuticals, Inc. and has been its Director since March 2011. He served as Member of Scientific Advisory Board at Vyteris, Inc. since July 2010. He serves as Independent Director of Evommune, Inc. since May 2020. He served as a Non-Employee Director at Dermira Inc. since June 2014 until February 19, 2020. He served as a Scientific Advisor of Dermira Inc. He has been an Independent Director of Kadmon Holdings, Inc. since February 7, 2019 and has served as its Director since 2014. He served as a Director of Stiefel West Coast LLC since December 2005. He served as a Director of Vyteris, Inc. since June 15, 2011 until 2012. He served as a Director of Brickell Biotech, Inc. He served as a Director of Connetics Corporation since December 2005. Dr. Cohen is also an active investigator in clinical trials for new treatments for skin diseases. Dr. Cohen is the Past President of the American Dermatological Association and served as President of the American Contact Dermatitis Society, the Dermatology Section of the New York Academy of Medicine and the New York Dermatological Association. He is a Member of the American Contact Dermatitis Society, Fellow of the American Academy of Dermatology and Diplomat of the American Board of Dermatology and American Board of Preventative Medicine-Occupational/Environmental Medicine. Dr. Cohen has published numerous scientific and medical articles in peer review journals including Journal of the American Academy of Dermatology, Archives of Dermatology, American Contact Dermatitis Journal and the International Journal of Dermatology. Dr. Cohen served as a founding board member for the American Acne and Rosacea Society and led the national guidelines of care for individuals with Latex allergy and served on the panel to establish the national guidelines of care for Atopic Dermatitis for the American Academy of Dermatology. He has been honored by election to Alpha Omega Alpha, the medical honor society and received the Merck Sharp Dohme Award for Academic Excellence. He is a Summa Cum Laude graduate of City University of New York. Dr. Cohen received a B.S. in biomedical science from the City University of New York, an M.D. from State University of New York at Stony Brook School of Medicine and an M.P.H. in environmental science from Columbia University School of Public Health.
Positions
- Company NameEvommune, Inc.Stock CodeEVMNPositionIndependent DirectorColleagues
- LCLuis C. PenaFounder, President, CEO & Director
- BFBenjamin F. McGrawIndependent Chairman of the Board
- KCKyle CarverChief Financial Officer
- GSGregory S. MossChief Business & Legal Officer, Corporate Secretary and Chief Compliance Officer
- EAEugene Andrew BauerCo-Founder, Chief Medical Officer & Director
- JPJeegar PatelChief Scientific Officer
- ASArthur S. KirschIndependent Director
